| Accurate bond and angle parameters for X-ray protein structure refinement RA Engh, R Huber Foundations of Crystallography 47 (4), 392-400, 1991 | 3338 | 1991 |
| The 2.0 AX‐ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. W Bode, R Engh, D Musil, U Thiele, R Huber, A Karshikov, J Brzin, J Kos, ... The EMBO journal 7 (8), 2593-2599, 1988 | 780 | 1988 |
| The refined 2.15 AX‐ray crystal structure of human liver cathepsin B: the structural basis for its specificity. D Musil, D Zucic, D Turk, RA Engh, I Mayr, R Huber, T Popovic, V Turk, ... The EMBO journal 10 (9), 2321-2330, 1991 | 778 | 1991 |
| Crystal Structure of the Xanthine Oxidase-Related Aldehyde Oxido-Reductase from D. gigas MJ Romao, M Archer, I Moura, JJG Moura, J LeGall, R Engh, M Schneider, ... Science 270 (5239), 1170-1176, 1995 | 604 | 1995 |
| Phosphotransferase and substrate binding mechanism of the cAMP‐dependent protein kinase catalytic subunit from porcine heart as deduced from the 2.0 A structure of the complex … D Bossemeyer, RA Engh, V Kinzel, H Ponstingl, R Huber The EMBO journal 12 (3), 849-859, 1993 | 490 | 1993 |
| International Tables for Crystallography, Vol. F, edited by MG Rossmann & E. Arnold RA Engh, R Huber Dordrecht: Kluwer Academic Publishers, 2001 | 390 | 2001 |
| Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53 R Stoll, C Renner, S Hansen, S Palme, C Klein, A Belling, W Zeslawski, ... Biochemistry 40 (2), 336-344, 2001 | 381 | 2001 |
| X-ray structure of active site-inhibited clotting factor Xa: implications for drug design and substrate recognition H Brandstetter, A Kühne, W Bode, R Huber, W von der Saal, ... Journal of Biological Chemistry 271 (47), 29988-29992, 1996 | 353 | 1996 |
| Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89: structural implications … RA Engh, A Girod, V Kinzel, R Huber, D Bossemeyer Journal of Biological Chemistry 271 (42), 26157-26164, 1996 | 344 | 1996 |
| Crystal structure of a thermostable type B DNA polymerase from Thermococcus gorgonarius KP Hopfner, A Eichinger, RA Engh, F Laue, W Ankenbauer, R Huber, ... Proceedings of the National Academy of Sciences 96 (7), 3600-3605, 1999 | 288 | 1999 |
| Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential L Prade, RA Engh, A Girod, V Kinzel, R Huber, D Bossemeyer Structure 5 (12), 1627-1637, 1997 | 231 | 1997 |
| Protein kinase A in complex with Rho-kinase inhibitors Y-27632, Fasudil, and H-1152P: structural basis of selectivity C Breitenlechner, M Gaßel, H Hidaka, V Kinzel, R Huber, RA Engh, ... Structure 11 (12), 1595-1607, 2003 | 226 | 2003 |
| Protein kinase inhibition of clinically important staurosporine analogues OA Gani, RA Engh Natural product reports 27 (4), 489-498, 2010 | 178 | 2010 |
| The 1.8-Å crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition H Brandstetter, F Grams, D Glitz, A Lang, R Huber, W Bode, HW Krell, ... Journal of Biological Chemistry 276 (20), 17405-17412, 2001 | 164 | 2001 |
| Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding KP Hopfner, A Lang, A Karcher, K Sichler, E Kopetzki, H Brandstetter, ... Structure 7 (8), 989-996, 1999 | 146 | 1999 |
| Differential sensitivity of ERBB2 kinase domain mutations towards lapatinib RK Kancha, N von Bubnoff, N Bartosch, C Peschel, RA Engh, J Duyster PloS one 6 (10), e26760, 2011 | 143 | 2011 |
| Structure-based optimization of novel azepane derivatives as PKB inhibitors CB Breitenlechner, T Wegge, L Berillon, K Graul, K Marzenell, WG Friebe, ... Journal of medicinal chemistry 47 (6), 1375-1390, 2004 | 142 | 2004 |
| Lysine 156 promotes the anomalous proenzyme activity of tPA: X‐ray crystal structure of single‐chain human tPA M Renatus, RA Engh, MT Stubbs, R Huber, S Fischer, U Kohnert, W Bode The EMBO journal, 1997 | 142 | 1997 |
| Structural aspects of protein kinase control—role of conformational flexibility RA Engh, D Bossemeyer Pharmacology & therapeutics 93 (2-3), 99-111, 2002 | 137 | 2002 |
| The interaction of insulin‐like growth factor‐I with the N‐terminal domain of IGFBP‐5 W Żesławski, HG Beisel, M Kamionka, W Kalus, RA Engh, R Huber, ... The EMBO journal, 2001 | 134 | 2001 |
Hans BrandstetterUniversity of SalzburgZweryfikowany adres z sbg.ac.at
